2002Unpublished venueRequires access

Comparison of effect of Losartan and Perindopril on microalbuminuria excretion in patients with hyperten- sion

Meiling Jin

Open publisher page 0 citations

Abstract

To compare the effect of angiotension Ⅱ receptors antagonists (AⅡA) losartan and angiotensin-converting enzyme inhibitor (ACEI) perindopril on microalbuminuria excretion in patients with hypertension. Methods: Sixty patients with essential hypertension were allocated randomly into two groups. Patients in losartan group (n -30) received losartan 50mg qd, for 4 weeks. Patients in perindopril group (n =30) received perindopril 4mg qd, for 4 weeks. Blood pressure and microalbumin were determined before and after the treatment. Results: After treatment, the blood pressure of patients in two groups are all lowered to normal and the excretion of microalbuminuria reduced obviously (P0.01). Furthermore, the efficacy of losartan was better than perindopril (P0.05). Conclusions: AⅡA and ACEI can reduced the excretion of microalbuminuria of patients with hypertension effectively, and the efficacy of A Ⅱ A is better than ACEI.

About this research paper

What this paper is about

To compare the effect of angiotension Ⅱ receptors antagonists (AⅡA) losartan and angiotensin-converting enzyme inhibitor (ACEI) perindopril on microalbuminuria excretion in patients with hypertension. Methods: Sixty patients with essential hypertension were allocated randomly into two groups. Patients in losartan group (n -30) received losartan 50mg qd, for 4 weeks. Patients in perindopril group (n =30) received perindopril 4mg qd, for 4 weeks. Blood pressure and microalbumin were determined before and after the treatment. Results: After treatment, the blood pressure of patients in two groups are all lowered to normal and the excretion of microalbuminuria reduced obviously (P0.01). Furthermore, the efficacy of losartan was better than perindopril (P0.05). Conclusions: AⅡA and ACEI can reduced the excretion of microalbuminuria of patients with hypertension effectively, and the efficacy of A Ⅱ A is better than ACEI.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To compare the effect of angiotension Ⅱ receptors antagonists (AⅡA) losartan and angiotensin-converting enzyme inhibitor (ACEI) perindopril on microalbuminuria excretion in patients with hypertension. Methods: Sixty patients with essential hypertension were allocated randomly into two groups. Patients in losartan group (n -30) received losartan 50mg qd, for 4 weeks. Patients in perindopril group (n =30) received perindopril 4mg qd, for 4 weeks. Blood pressure and microalbumin were determined before and after the treatment. Results: After treatment, the blood pressure of patients in two groups are all lowered to normal and the excretion of microalbuminuria reduced obviously (P0.01). Furthermore, the efficacy of losartan was better than perindopril (P0.05). Conclusions: AⅡA and ACEI can reduced the excretion of microalbuminuria of patients with hypertension effectively, and the efficacy of A Ⅱ A is better than ACEI.

Key concepts: Perindopril, Losartan, Microalbuminuria, Medicine, Excretion, Blood pressure, Internal medicine, Essential hypertension

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of effect of Losartan and Perindopril on microalbuminuria excretion in patients with hyperten- sion — Research Paper | ScholarLens